P0815 : Cost-effectiveness of treating different stages of genotype 1 hepatitis C Virus (HCV) with AbbVie 3D (ABT-450/ritonavir/ombitasvir and dasabuvir) +/− ribavirin compared to no treatment in the United States

Autor: Johnson, S.J., Misurski, D.A., Juday, T.R., Samp, J.C., Marx, S.E., Parisé, H., Virabhak, S., Saab, S.
Zdroj: In Journal of Hepatology April 2015 62 Supplement 2:S641-S642
Databáze: ScienceDirect
Externí odkaz: